Glaukos Corporation

NYSE:GKOS

Medical - Devices

Healthcare
$233.08 -0.14%

-$0.18 today

Market cap
$13.80B
Beta
0.81
P/E (TTM)
-39.0
EPS (TTM)
-$3.26
52W Low $73.16High $148.11

Volume 1.12M

Average 0.94M

GKOS Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Glaukos CorporationNYSE: GKOS

Weighted Avg Shares (Diluted) · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q2 FY2026 weighted avg shares (diluted) of 58.42M shares rose 2.1% year over year, behind the +3.1% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.7% from the prior quarter. Over 3 fiscal years it compounded at +6.4% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +2.1% toward the trailing-twelve-month pace of +3.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
58.42M+0.7% QoQ
Last fiscal yearDec 2025
57.19M+8.4% YoY
LTMJun 2026
57.84M+3.1% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2.1%——
1 year+8.4%——
3-year CAGR+6.4%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
57.19M USD
Year-over-year change
+8.4%
4-year CAGR
+5.4%

Weighted Avg Shares (Diluted) vs competitors

How GKOS compares with its peers on the latest reported figures

  • GKOS's LTM Jun 2026 weighted avg shares (diluted) of 57.84M shares is the 5th highest of the 9 companies compared; the peer median is 65.04M shares.
  • Its year-over-year change of +3.1% is the 5th highest of 8, against a peer median of +3.2%.
  • Over three fiscal years its annual growth of +6.4% compares with a peer median of +2.9%.
GKOS Competitors Peer median
Weighted Avg Shares (Diluted) for GKOS and competitors
Company Period LTM YoY 3-year CAGR
ALCAlcon Inc.LTM Sep 2026488.63M -1.7%+0.1%
BLCOBausch + Lomb CorporationLTM Jun 2026355.23M +0.6%+0.4%
OCULOcular Therapeutix, Inc.LTM Mar 2026200.88M +19.9%+31.3%
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 202677.28M +27.7%+25.2%
GKOSGlaukos CorporationLTM Jun 202657.84M +3.1%+6.4%
SGHTSight Sciences, Inc.LTM Mar 202652.81M +4.4%+2.9%
STAASTAAR Surgical CompanyLTM Apr 202649.88M +0.7%+0.1%
RXSTRxSight, Inc.LTM Mar 202641.05M +3.2%+14.2%
SGPSpyGlass Pharma, Inc. Common StockFY202533.43M ——
Peer median (excluding GKOS) 65.04M+3.2%+2.9%

Competitors are the stored peer set for GKOS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue294.01M282.86M314.71M383.48M507.44M
Cost of Revenue66.63M68.98M75.58M94.03M114.23M
Gross Profit227.38M213.88M239.14M289.45M393.22M
Gross Margin77.3%75.6%76.0%75.5%77.5%
Research & Development101M123.27M138.77M136.43M150.61M
Selling, General & Admin179.26M192.93M224.07M262.85M329.34M
Operating Expenses260.26M296.2M367.84M411.82M479.95M
Depreciation & Amortization34.42M35.95M37.98M39.92M42.35M
EBITDA(1.47M)(48.76M)(82.12M)(95.64M)(146.06M)
EBITDA Margin-0.5%-17.2%-26.1%-24.9%-28.8%
Operating Income(32.87M)(82.31M)(128.7M)(122.37M)(86.73M)
Operating Margin-11.2%-29.1%-40.9%-31.9%-17.1%
Interest Income1.29M2.38M9.16M11.11M10.71M
Interest Expense13.37M13.72M13.63M10.04M4.64M
Other Income / Expenses(16.4M)(16.12M)(5.03M)(23.24M)(106.31M)
Income Before Tax(49.27M)(98.43M)(133.73M)(145.6M)(193.04M)
Pre-Tax Margin-16.8%-34.8%-42.5%-38.0%-38.0%
Income Tax Expense326K766K934K771K(5.35M)
Net Income(49.59M)(99.2M)(134.66M)(146.37M)(187.69M)
Net Margin-16.9%-35.1%-42.8%-38.2%-37.0%
EPS (Basic)(1.07)(2.09)(2.78)(2.77)(3.28)
EPS (Diluted)(1.07)(2.09)(2.78)(2.77)(3.28)
Weighted Avg Shares46.42M47.44M48.43M52.76M57.19M
Weighted Avg Shares (Diluted)46.42M47.44M48.43M52.76M57.19M

Glaukos Corporation

NYSE:GKOS

Intrinsic Alpha fair value

Locked

Current Price

$233.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.